➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Colorcon
McKesson
McKinsey
Baxter

Last Updated: April 22, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR GENOSYL

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for GENOSYL

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01265888 Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Completed Geno LLC Phase 2 2011-03-01 A Phase 2 open label, dose escalation study to find the minimally and maximum effective dose (dose beyond which no further effect on PVR is seen) of inhaled nitric oxide generated by the GeNOsyl® System compared to placebo.
NCT02436512 Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide Withdrawn Geno LLC Phase 3 2015-06-01 The EAGLE study is a Phase 3, open-label, multi-center, two-part, single-arm study of GeNOsyl(R) delivery system(s) to evaluate if inhaled nitric oxide-induced vasodilation predicts successful wean from parenteral prostacyclin (PGI) in subjects with World Health Organization (WHO) Group 1 pulmonary arterial hypertension (PAH) undergoing a medically necessary right heart catheterization (RHC). All subjects enrolled in the study will undergo an attempt to wean from parenteral PGI per standard of care.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for GENOSYL

Condition Name

Condition Name for GENOSYL
Intervention Trials
Pulmonary Arterial Hypertension 2
Idiopathic Pulmonary Fibrosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for GENOSYL
Intervention Trials
Hypertension 2
Familial Primary Pulmonary Hypertension 2
Pulmonary Fibrosis 1
Idiopathic Pulmonary Fibrosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for GENOSYL

Trials by Country

Trials by Country for GENOSYL
Location Trials
United States 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for GENOSYL
Location Trials
Alabama 2
Pennsylvania 1
Utah 1
Texas 1
Ohio 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for GENOSYL

Clinical Trial Phase

Clinical Trial Phase for GENOSYL
Clinical Trial Phase Trials
Phase 3 1
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for GENOSYL
Clinical Trial Phase Trials
Completed 1
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for GENOSYL

Sponsor Name

Sponsor Name for GENOSYL
Sponsor Trials
Geno LLC 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for GENOSYL
Sponsor Trials
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Harvard Business School
Johnson and Johnson
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.